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Abstract The Generation R Study is a population-based
prospective cohort study from fetal life until young adult-
hood. The study is designed to identify early environmental
and genetic causes of normal and abnormal growth,
development and health during fetal life, childhood and
adulthood. The study focuses on four primary areas of
research: (1) growth and physical development; (2)
behavioural and cognitive development; (3) diseases in
childhood; and (4) health and healthcare for pregnant
women and children. In total, 9,778 mothers with a
delivery date from April 2002 until January 2006 were
enrolled in the study. General follow-up rates until the age
of 4 years exceed 75%. Data collection in mothers, fathers
and preschool children included questionnaires, detailed
physical and ultrasound examinations, behavioural obser-
vations, and biological samples. A genome wide associa-
tion screen is available in the participating children.
Regular detailed hands on assessment are performed from
the age of 5 years onwards. Eventually, results forthcoming
from the Generation R Study have to contribute to the
development of strategies for optimizing health and
healthcare for pregnant women and children.
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Introduction
The Generation R Study is a population-based prospective
cohort study from fetal life until young adulthood. The
study is designed to identify early environmental and
genetic causes of normal and abnormal growth, develop-
ment and health during fetal life, childhood and adulthood.
The study focuses on four primary areas of research: (1)
growth and physical development; (2) behavioural and
cognitive development; (3) diseases in childhood; and (4)
health and healthcare for pregnant women and children.
The background and specific lines of investigation have
been described in detail previously [1–3]. The main out-
comes and determinants are presented in Tables 1 and 2.
The general aims of the study are: (1) To describe normal
and abnormal growth, development and health from fetal
life until young adulthood; (2) To identify biological,
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environmental and social determinants of normal and
abnormal growth, development and health from fetal life
until young adulthood; (3) To develop and evaluate strat-
egies for prevention and early identification of groups at
risk.
Special interest is in exploring the role of early envi-
ronmental exposures and genetic variants in pathways
leading to common diseases during fetal life, childhood and
adulthood, of which various examples have been published
in this journal [4–15].
Main outcomes include risk factors for cardiovascular
disease, type 2 diabetes, obesity, asthma, psychopathology
and riks factors such as impaired physical activity [16–
70]. Results forthcoming from the Generation R Study
have to contribute to the development of strategies for
optimizing health and healthcare for pregnant women and
children.
Study area
The Generation R Study is conducted in Rotterdam, the
second largest city in the Netherlands. Rotterdam is situ-
ated in the Western part of the Netherlands on almost
80 km south from Amsterdam, the capital of the Nether-
lands. The total population consists of about 600,000
inhabitants of almost 150 different ethnicities. The study
area is well defined by postal codes and covers more than
half of the cities inhabitants (almost 350,000 inhabitants)
[16]. The largest ethnic groups in this population are the
Dutch (56%), Surinamese (9%), Turkish (7%), Moroccan
(6%), Dutch Antillean (3%) and Cape Verdian (3%) groups
[2]. The percentages of the non-Dutch groups are higher in
younger age groups [2]. The number of children born in
this study area is about 4,300 per year. Measurements in
the prenatal phase of the study were conducted in two well-
equipped research centers in the study area, with a close
collaboration with midwives and hospitals. In the preschool
period, detailed measurements were conducted in a dedi-
cated research center in the Erasmus Medical Center—
Sophia Children’s Hospital and routine care data were
collected in five hospitals and sixteen child health centers
located in this area.
Study design
Overview
The Generation R Study is a population-based prospective
cohort study from fetal life until young adulthood. Mothers
Table 1 Main outcomes per research area
Growth and physical development
Fetal growth patterns and organ development
Pregnancy complications
Postnatal growth patterns
Body composition and obesity
Risk factors for development of cardiovascular disease
Risk factors for type 2 diabetes
Behavioural and cognitive development
Fetal and postnatal brain development
Behavioural and emotional problems
Child psychopathology
Neuromotor development
Verbal and nonverbal cognitive development
Neuropsychology—executive function
Chronic pain
Attachment
Stress reactivity
Compliance and moral development
Diseases in childhood
Infectious diseases in childhood
Bacterial carriage
Abdominal symptoms and celiac disease
Development of the immune system
Asthma, eczema and related symptoms
Paroxysmal neurological disorders
Febrile seizures
Tooth development
Health and healthcare
Social en ethnic health inequalities
Quality of life
Health care utilization
Effectiveness of screening programmes
Table 2 Main determinants
Biological determinants
Parental anthropometrics and blood pressure
Fetal and postnatal growth characteristics
Endocrine and immunological factors
Genetic variants/genome wide association scan
Environmental determinants
Maternal prenatal diet and childhood diet, and their biomarkers
Parental life style habits (including smoking, alcohol
consumption)
Air pollution
Housing conditions
Home environment
Social determinants
Parental education, employment status and household income
Parental marital status
Parental psychopathology
Ethnicity
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with a delivery date between April 2002 and January 2006
were eligible. Extensive assessments have been carried out
in mothers and fathers and are currently performed in their
children (Tables 3, 4). Assessments in pregnancy were
planned in early pregnancy (gestational age \ 18 weeks),
mid-pregnancy (gestational age 18–25 weeks) and late
pregnancy (gestational age [ 25 weeks). These measure-
ments are considered as first, second and third trimester
measurements. The fathers were assessed once in preg-
nancy. The children form a prenatally recruited birth-
cohort that will be followed until young adulthood. In the
preschool period, which in the Netherlands refers to the
period from birth to the age of 4 years, data collection was
performed by a home-visit at the age of 3 months, ques-
tionnaires at the ages of 2, 6, 12, 18, 24, 30, 36 and
48 months and visits to the routine child health centres at
the ages 2, 3, 4, 6, 11, 14, 18, 24, 30, 36 and 45 months
(Table 4). Additional, more detailed assessments of fetal
and postnatal growth and development have been con-
ducted in a randomly selected subgroup of Dutch children
and their parents at a gestational age of 32 weeks and
postnatally at the ages of 1.5, 6, 14, 24, 36 and 48 months
(Tables 3, 4).
Dutch is defined as two parents and four grandparents
born in the Netherlands. From the age of 5 years onwards,
regular detailed hands on assessment are performed in all
children and their parents in a well-equipped, dedicated
research center.
Eligibility and enrolment
Eligible mothers were those who were resident in the study
area at their delivery date and had a delivery date from
April 2002 until January 2006. We aimed to enroll mothers
in early pregnancy (gestational age \ 18 weeks) but
enrolment was allowed until birth of their child. Midwives
and obstetricians informed eligible mothers about the study
Table 3 Assessments in
mothers, fathers and their
children in the prenatal phase
? = Assessment in whole
cohort
S = Assessment only in
subgroup
Early pregnancy: gestational
age \ 18 weeks; mid-
pregnancy: gestational age
18–25 weeks; late pregnancy:
gestational age [ 25 weeks
Early pregnancy Mid-pregnancy Late pregnancy Birth
Mother
Physical examination ? ? ?
Questionnaire ? ? ?
Interview S
Fetal ultrasound examination ? ? ?
Detailed fetal ultrasound S
Blood sample ? ?
Urine sample ? ? ?
Father
Physical examination ?
Questionnaire ?
Interview
Blood sample ?
Child
Physical examination ?
Cord blood ?
Table 4 Assessments in mothers, fathers and children during the
preschool period
Age (months)
2 3 4 6 11 12 14 18 24 30 36 45 48
Child
Questionnaire
(parent)
? ? ? ? ? ? ? ?
Physical
examination
? ? ? ? ? ? ? ? ?
Ultrasound S S S
Airway
inflammation
S S
Behavioural
observation
S S S
Bacterial
carriage
S S S S
Blood sample S S
Mother specific
Questionnaire ? ? ? S
Interaction with
child
S S
Father specific
Questionnaire ?
Interaction with
child
S
? = Assessment in whole cohort
S = Assessment only in subgroup
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at their first prenatal visit in routine care, handed out the
information package and asked these mothers to make an
appointment for the first ultrasound examination. The study
staff contacted these mothers by phone for additional
information about the study and in person at the ultrasound
examination to obtain informed consent. Mothers who
were not approached in pregnancy, were approached and
enrolled in the first months after birth of their child when
newborns visit the routine child health centers [2]. The
fathers were not approached directly by the study staff but
the mothers were informed about the importance of
involvement of the fathers in the study.
Study cohort
Parents
In total, 9,778 mothers were enrolled in the study (Fig. 1).
Of these mothers, 91% (n = 8,880) was enrolled in preg-
nancy. Only partners from mothers enrolled in pregnancy
were invited to participate. In total, 71% (n = 6,347) of all
fathers was enrolled. The general characteristics of the
mothers and fathers are presented in Table 5. Of all par-
ticipating mothers, enrolment was in early pregnancy in
69% (n = 6,691), in mid-pregnancy in 19% (n = 1,918),
in late pregnancy in 3% (n = 271) and at birth of their
child in 9% (n = 898). Of all pregnant women enrolled,
94% (n = 8,356), 6% (n = 516) and 0.1% (n = 8) were
first, second and third pregnancies in the study, respec-
tively. A total of 1,232 pregnant women and their children
were enrolled in the subgroup for additional detailed
studies. Ethnicity of participating mothers and partners was
defined according the classification of Statistics Nether-
lands [71, 72]. The largest ethnic groups were the Dutch,
Surinamese, Turkish and Moroccan groups. The ethnic
distribution differed only moderately from that of the
population in the study area [71]. Mean household income
in Rotterdam is about €1600 per month and the percentage
subjects with a secondary or higher education level in
Rotterdam is 56% [71]. The educational level of partici-
pating mothers and their partners was classified in groups
according to the classification of Statistics Netherlands
[73]. Ethnic background, educational level and occupa-
tional status are of major interest and are studied as
determinants of health and behavioural outcomes [74–91].
Both household income and highest followed educational
level in mothers and fathers in the study cohort suggest a
selection towards a higher socioeconomic status than in the
whole study. This pattern is similar as in other large scale
cohort studies [92]. However, differences between the
population and cohort characteristics may also be due to
selective missing values of ethnicity and socio-economic
status in the questionnaires. Socio-economic status is
related to various perinatal and postnatal health outcomes
and of major interest in the study [93–109].
Children at birth and overall response
Among the live births, 51% were male and 49% female.
These percentages are similar to the population figures in
the Netherlands and in Rotterdam [71]. The percentages of
children born preterm or with low birth weight are smaller
than expected on the basis of the population figures. This
Enrolment 
Mothers 9,778 
8880 in pregnancy, 898 at birth of their child 
Fathers 6,347 
Birth 
Children 9,745 
1,163 excluded from postnatal follow up (see text) 
689 no consent for postnatal studies  
7,893 children for follow up studies 
Data collection in mothers (n = 8,880) 
Visits 
Early pregnancy 76% (n = 6,752) 
Mid-pregnancy 93% (n = 8,265) 
Late pregnancy 94% (n = 8,334) 
Questionnaires 
Mother 1  91% (n = 8,116) 
Mother 2  81% (n = 7,229) 
Mother 3  80% (n = 7,145) 
Mother 4  77% (n = 6,830) 
Blood samples 
Early pregnancy 72% (n = 6,398) 
Mid-pregnancy 86% (n = 7,616) 
Urine samples (limited period)  
Early pregnancy 85% (n = 2,375) 
Mid-pregnancy 97% (n = 3,279) 
Late pregnancy 96% (n = 3,762) 
Data collection in fathers (n =6,347) 
Visit  100% (n = 6,374) 
Questionnaire 82%  (n = 5,177) 
Blood sample 82%  (n = 5,198) 
Data collection in children (n = 7,893) 
Questionnaires (see text) 
2 months  82% (n = 5,202)  
6 months  73% (n = 4,382) 
12 months 72% (n = 5,214) 
12 months diet (S) 71% (n = 3,609) 
18 months 75% (n = 5,322) 
24 months 76% (n = 5,416) 
24 months diet (S)   89% (n = 842) 
30 months 68% (n = 4,766) 
36 months 69% (n = 5,015) 
48 months 73% (n = 5,009) 
Visits child health centres 
0-6 months 84% (n = 6,591) 
6-12 months 81% (n = 6,414) 
12-18 months 77% (n = 6,088) 
18-24 months 57% (n = 4,478) 
24-36 months 68% (n = 5,335) 
36-48 months 70% (n = 5,513) 
Focus visits 
1.5 months 81% (n = 900)  
6 months  81% (n = 901) 
14 months 80% (n = 882) 
24 months 77% (n = 856) 
36 months 78% (n = 862) 
48 months 68% (n = 752) 
From the age of 5 years 
Regular hands on assessments  
Fig. 1 Enrolment and measurements until the age of 4 years
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seems to reflect a selection toward a relative more healthy
study population. Estimation of the precise number of
eligible pregnant women in the study area is difficult since
there is no satisfactory registry of pregnancies. Therefore,
it was not attempted to identify overall response rates of
pregnant women. Since the children form a prenatally
recruited birth-cohort, the overall response of the study has
been established at birth and is 61%.
Participation in postnatal follow up studies
As described above, 9,778 mothers were enrolled in the
study and gave birth to 9,745 known live born children.
The logistics of the postnatal follow up studies were
embedded in the municipal routine child care system and
restricted to the study area. In total 1,163 children lived
outside this definite study area at birth and were therefore
not approached for the postnatal follow up studies during
the preschool period. Of the remaining 8,582 children, 689
(8%) mothers did not give consent for the postnatal phase
of the study leaving 7,893 children for the postnatal follow-
up studies. Reasons for non-participation in the postnatal
follow up studies were primarily time restrictions or plans
for moving from the study area. Of the total of 7,893
mothers, 598 (7.5%) gave a restricted consent and did not
want to participate in the questionnaire studies. In total
7588 (78%) children or their parents participated in at least
one measurement during the preschool period, of whom
6845 (90%) completed at least one questionnaire.
Data collection in the prenatal phase
Physical examinations
Physical examinations were planned at each visit in early
pregnancy, mid-pregnancy and late pregnancy and inclu-
ded height, weight and blood pressure measurements of
both parents. Overall response rates for these specific
measurements in mothers and fathers are similar as the visit
percentages presented in Fig. 1. Since there was a wide
range of gestational age at each visit, these measurements
are used in the analyses as gestational age adjusted mea-
surements [110].
Questionnaires
Mothers received four postal questionnaires and father
received one postal questionnaire in the prenatal phase
(Table 3). All questionnaires are available in three lan-
guages (Dutch, English and Turkish). If needed, further
support for verbal translation of questionnaires is available
in Arabic, Portuguese and French. Each questionnaire
comprises about 25 pages and takes about 30–45 min to be
completed [2]. Topics in these questionnaires were:
– Mother 1: medical and family history, previous preg-
nancies, quality of life, life style habits, housing
conditions, ethnicity, educational level;
– Mother 2: diet, including macronutrients and
micronutrients;
– Mother 3: current pregnancy, quality of life, life style
habits, psychopathology;
– Mother 4: current pregnancy, quality of life, life style
habits, working conditions, household income, self-
esteem;
– Father: medical history, family history, life style habits,
educational level, psychopathology.
Overall response rates for these questionnaires varied
from 77 to 91% (Fig. 1). However, the response rates of
specific questions may be lower due to missing values
within questionnaires.
Table 5 Characteristics of mothers and their partners
Mothers Partners
(n = 9,778) (n = 6,347)
Gestational age at enrolment (%)
Early pregnancy 69 –
Mid-pregnancy 19 –
Late pregnancy 3 –
Birth 9 –
Pregnancy number in study (%)
1st pregnancy 94 –
2nd pregnancy 6 –
3rd pregnancy 0.1 –
Age at enrolment (years)a 29.9 (5.4) 32.7 (5.7)
Parity (%)
0 55 –
1 30 –
C2 15 –
Ethnicity (%)
Dutch, other-European 59 68
Surinamese 9 7
Moroccan 6 4
Turkish 9 7
Dutch Antilles 3 3
Cape verdian 4 2
Others 10 9
Highest completed education (%)
Primary school 11 8
Intermediate 46 41
Higher 43 51
Values are percentages. a Mean (standard deviation)
The Generation R Study 827
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Fetal ultrasound examinations
Fetal ultrasound examinations were performed at each
prenatal visit. Overall response rates for these ultrasound
examinations were in general similar to the visit percent-
ages given in Fig. 1. These ultrasound examinations were
used for both establishing gestational age and assessing
fetal growth patterns. These methods have previously been
described in detail [111, 112]. Establishing gestational age
by using the first day of the last menstrual period is not
reliable for a variety of reasons including the large number
of women who do not know their exact date, have irregular
menstrual cycles or amenorrhea, use oral contraceptive
pills or bleed in early pregnancy [113]. Using fetal ultra-
sound data such as crown-rump length or biparietal diam-
eter for pregnancy dating seems to overcome these
problems but does not allow growth studies of these
measurements since no growth variability between subjects
is assumed. Pregnancy dating-curves have been derived in
a subsample of the cohort including subjects with complete
data on both the first day of the last menstrual period and
crown-rump length or biparietal diameter and used to date
the gestational age [111]. Subsequently, longitudinal
curves of all fetal growth measurements (head circumfer-
ence, biparietal diameter, abdominal circumference and
femur length) were created resulting in standard deviation
scores for all of these specific growth measurements.
Various sociodemographic and lifestyle related determi-
nant seems to affect these fetal growth and birth outcomes
[114–119]. Also, specific fetal growth patterns seem to be
associated with outcomes in childhood [120–123]. We
have demonstrated in a subgroup study among mothers
with a known and reliable last menstrual period, that var-
ious life style related factors affect first trimester growth
[124]. Placental haemodynamics including resistance
indices of the uterine and umbilical arteries have been
assessed in second and third trimester [125]. Detailed
measurements of fetal brain, cardiac and kidney develop-
ment have been performed in the subcohort [126–129].
Pregnancy complications and outcomes
The obstetric records of mothers have been looked up in
the hospitals and mid-wife practices. Specialists in the
relevant field code items in these records, and used for
validation studies for maternal reported data [130, 131].
The major pregnancy outcomes, including live births,
induced abortion fetal or perinatal loss, pregnancy induced
hypertension, preeclampsia, and gestational diabetes are
known in 99% of all enrolled mothers. These outcomes are
related to various exposures of interest [132–148]. In all
children known to be born alive, information about sex,
birth weight and gestational age is available. Currently,
efforts are made to link the Generation R dataset to existing
national databases for pregnancy and the neonatal period
[149, 150].
Biological samples
Blood samples were collected in early and mid-pregnancy
and at birth. Procedures for collection, processing and
storage of biological samples have been described previ-
ously in detail [151]. The planned amounts of venous blood
taken were 35 and 20 ml in early pregnancy and mid-
pregnancy, respectively, from the mother and 10 ml from
father. At delivery, 30 ml cord blood was collected. Blood
samples are currently available for 97, 83 and 67% of the
participating mothers, partners and children, respectively.
Due to several clinical complications in mother and child,
it was not always possible to collect cord blood. Subse-
quently, availability rates of cord blood samples in children
born preterm or with low birth weight are lower than
expected. Plasma and serum samples has been distributed
in small aliquots (each 250 ll) and stored at -80C.
Maternal and cord blood samples have been used for
measuring dietary biomarkers (folate, homocystein, total
vitamin B12, free vitamin B12) levels; angiogenesis bio-
markers (soluble fms-like tyrosine kinase-1 (sFlft-1), Pla-
cental growth factor (PlGF)); thyroid hormone levels
(thyroid-stimulating hormone (TSH), free thyroxine (FT4))
and thyroid antibody levels, inflammation markers (high-
sensitivity C-reactive protein (hs CRP); and celiac disease
and Helicobacter Pylori antibodies [152–154]. Urine sam-
ples of mothers have been collected from February 2004
until November 2005 and are stored for future measure-
ments. Response rates for these urine samples are 85, 97
and 96% in early, mid- and late pregnancy respectively.
These urine samples are used for measurement of several
environmental exposures, and metabolites. Urine samples
have been used for measurement of Chlamydia, and pes-
ticides, bisphenol A, and phthalates levels [155, 156].
DNA and genome wide association studies
DNA from both parents (whole blood) and children (cord
blood) has been extracted, normalised and plated and is
currently used for several genotype studies. A genome wide
association scan (GWAS) using the Illumina 610 Quad
platform is available for the participating children. For
genotyping, we used the infrastructure of the Genetic
Laboratory of the Department of Internal Medicine
(www.glimdna.org) that was also used for creation of the
GWAS datasets of the Rotterdam Study, a prospective
cohort study among more than 10,000 adults [157, 158].
The GWAS dataset underwent a stringent QC process
whereby Individuals with low call rates or sex mismatches
828 V. W. V. Jaddoe et al.
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were excluded, and SNPs with low call rates were excluded.
In addition, ethnic composition of the sample was estimated
by Identity-By-State Analysis, using Principal Component
Analysis, and cryptic familial relationships were identified
through Identity-By-Descent analysis]. To maximize gen-
ome coverage and allow inter-study comparisons, we used
MACH (version 1.0.15) software to impute genotypes at
each of the 2.5 million autosomal CEPH HapMap II
(release 22) SNPs for Europeans and European-Americans
[159]. Criteria such as high levels of missing data (SNP call
rate \ 98%), highly significant departures from Hardy-
Weinberg equilibrium (P \ 1.10–6), or low Minor Allele
Frequencies (MAF \ 1%) were used to determine which
SNPs to include in the imputation step. Most GWAS
analyses are strongly embedded in the recently started Early
Growth Genetics (EGG) Consortium and Early Genetics
and Longitudinal Epidemiology (EAGLE) Consortium, in
which several birth cohort studies combine their GWAS
efforts focused on multiple outcomes in fetal life, childhood
and adolescence [160, 161]. The power of large scale
consortia has been shown previously [162–170]. Also,
strategies for genetic scoring analyses are being developed
to estimate predictive values of identified genetic variants
[171, 172]. Although a GWAS is available in children, we
use DNA from both children and parents for genotyping for
candidate gene or replication studies [173–182]. Missing
data in DNA samples in children will be collected by blood
sampling or other methods at follow-up measurements.
Data collection in the first 4 postnatal years
Physical examinations
At the age of 3 months, home visits were performed to
assess neuromotor development using an adapted version
of Touwen’s Neurodevelopmental examination [183–185].
Information about growth (length (height), weight, head
circumference) is collected at each visit to the routine child
health centres in the study area using standardized proce-
dures. These visits are planned at the ages 2, 3, 4, 6, 11, 14,
18, 24, 30, 36 and 48 months. Response rates for these
visits vary between 70 and 97% [186].
Questionnaires
During the preschool period, mothers receive 8 question-
naires and fathers receive one questionnaire. Each ques-
tionnaire comprises about 25 pages. Items included in these
questionnaires and their references are demonstrated in
Table 6 [187–223]. Response rates based on the number of
send questionnaires are showed in Fig. 1. Due to logistical
constraints and implementation of questionnaires after the
first group of children reached a certain age, not all chil-
dren received each questionnaire. Thus, although response
rates may be similar, the absolute number of completed
questionnaires could differ between different ages.
Response rates presented in Fig. 1 are based on the number
of send questionnaires.
Hands on assessments and observations in subgroup
During the preschool period, children participating in the
subgroup studies have been invited six times to a dedicated
research center. Measurements at these visits included
physical examinations (height, weight, head circumference,
skinfold thickness and waist- hip ratio, Touwen’s Neuro-
developmental Examination at the ages of 1.5, 6, 14, and
24 months) and ultrasound examinations (brain structures
at 1.5 months and cardiac and kidney structures at the ages
of 1.5, 6 and 24 months, abdominal fat at the age of
24 months) [224–237]. Dual 9 Energy Absorptiometry
(DXA) scanning was performed in a subgroup of children
at the age of 6 months [238]. Similarly Fractional Exhaled
Nitric Oxide (FeNO) has been measured in only 50% of all
children at the ages of 6 and 24 months. Blood pressure
was measured at the age of 24 months [239]. Observations
of parent-child interaction and behaviour, such as executive
function, heart rate variability, infant-parent attachment,
moral development, and compliance with mother and child
have been performed at the ages of 14, 36 and 48 months
and with father and child at the age of 48 months [240,
241]. Biological materials have been collected, including
bacterial colonization measured by nasal- and nasopha-
ryngeal swabs at the ages of 1.5, 6, 14 and 24 months,
cortisol day rhythm measured by repeated salivary samples
at the age of 14 months and, if parents give consent, blood
samples at the ages of 6, 14 and 24 months [242–251].
Response rates for these blood samples are about 30%,
mainly because of lack of parental consent.
Measurements from the age of 5 years
From the age of 5 years onwards, we plan to invite all
participating children to a well-equipped and dedicated
research center in the Erasmus Medical Center—Sophia
Children’s Hospital every 3 years. Currently, all children
aged 5–6 years are invited to participate in hands on mea-
surements, behavioural observations and biological sample
collection. The total visit takes about 2.5 h and all mea-
surements are grouped in thematic 20 min blocks. These
measurements are focused on several health outcomes
including asthma, bacterial carriage, infectious diseases,
behaviour and cognition, body composition, eye and tooth
development, heart and vascular development, kidney
growth and function, and obesity. These measurements will
The Generation R Study 829
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Table 6 Themes in postnatal questionnaires until the age of 4 years
Main themes 2 months 6 months 12 months 18 months 24 months 30 months 36 monthse 48 months
Mother
General health
Quality of life [187, 188] ? ?
Pregnancy complications ?
Life events ?
Social and demographic factors
Housing conditionsa ? ? ? ?
Working conditions ?
Educational level and household income ? ?
Social support
Mental health and stress ?
Parenting [189, 190] ? ?
Depressive symptoms [191] ?
Psychopathology [192] ? ? ?
Child
Diet and physical activity
Dietb [193] ? ? ? ?/S
Eating behaviour [194] ? ?
Television watching, physical activity ? ? ?
Day-care ? ? ?
Childhood health and diseases
Quality of life [195] ? ?
Fever and infectious diseases [196, 198] ? ? ? ? ? ?
Asthma related symptoms and eczema
[199–204]
? ? ? ? ?
Accidents ? ? ?
Seizuresc [205] ? ? ? ? ? ?
Abdominal pain, stool pattern [206] ? ? ?
Doctors visit ? ? ? ? ?
Behaviour and cognition
Sleeping, crying and soothing [207, 208] ? ? ? ? ?
Temperament [209] ?
Motor development [210] ? ? ? ? ?
Behaviour and emotional problems
[211–217]d
? ? ?
Pain perception [218–220] ? ?
Language development [221] ? ?
Non verbal cognition [222] ? ?
Executive function [223] ?
? = Assessment in whole cohort. S = Assessment only in subgroup
a Housing conditions include information about family structure, (environmental) smoking and pets
b Diet questionnaires included in 2, 6 and 12 months questionnaire. Additional food frequency questionnaires at 12 months for all Dutch
speaking children and at 24 months for all focus cohort children
c Screening ten items questionnaire on seizures. Screen positives receive additional questionnaire and are being asked for their medical records
d Infant Behaviour Questionnaire at the age of 6 months, child behaviour checklist thereafter
e For parenting, psychopathology and child behaviour additional questionnaire for fathers
830 V. W. V. Jaddoe et al.
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be used as both outcomes and determinants for health out-
comes in later life. Cardiovascular, metabolic and bone
measurements are also conducted in mothers. Clinically
relevant results are discussed with the parents and, if
needed, children or mothers are referred to their general
practitioner, paediatrician or other relevant health care
provider. All children are expected to have visited our
research center in summer 2011. Currently ideas for follow
up studies including detailed imaging studies using
Magnetic Resonance Imaging (MRI), are discussed and
tested in subgroups.
Ethical issues
The general design, all research aims and the specific
measurements in the Generation R Study have been
approved by the Medical Ethical Committee of the Eras-
mus Medical Center, Rotterdam. New measurements will
only be embedded in the study after approval of the
Medical Ethical Committee. Participants are asked for their
written informed consent for the four consecutive phases of
the study (prenatally, birth to 4 years, 4–16 years, and from
16 years onwards). At the start of each phase, mothers and
their partners received written and oral information about
the study. Even with consent of the parents, when the child
is not willing to participate actively, no measurements are
performed.
Follow up and retention strategies
Thus far, loss to follow up seems to be limited. Major
efforts are made to keep the children and parents involved
in the study and to minimize loss to follow up to prevent
bias in future studies. Several strategies have been imple-
mented and are currently part of the study design:
– Addresses: new addresses of participants, which are
known by the municipal health service are forwarded to
the study staff;
– Newsletters: participants receive four newsletters per
year, in which several results of the study are presented
and explained, questions of participants are answered
and new research initiatives are presented;
– Presents and discounts: all children who visit our
research center receive small presents. Also, discount
offers are regularly part of the newsletter;
– Transport costs: all costs for transport and parking
related to visits to the research center are paid by
Generation R;
– Reminders for questionnaires: when the questionnaire
has not been returned within 3 weeks, a kind reminder
letter is send to the parents. After 6 weeks, when the
questionnaire has still not been returned, the parents
receive a phone call. If necessary, help for completing
the questionnaire is offered and the importance of
filling in the questionnaire is explained once more
during this phone call;
– Individual feedback: if clinically relevant, all results of
hands-on measurements are discussed with the parents
at the visit. If necessary, follow up appointments with
the general practitioner or pediatrician are planned;
– Support for ethnic minorities: all study materials such
as questionnaires, newsletters, website, and information
folders are available in three languages (Dutch,
English, and Turkish). Furthermore, staff from different
ethnic minorities is available and able to verbally
translate these materials into Arabic, French and
Portuguese. With this, the study staff is able to
communicate to all participants.
– Care-cases: children and parents who showed low
response rates for different measurements, showed
difficulties in completing questionnaires or require
additional explanation or support are considered as
care-cases. Care—cases have a more individual based
approach and are pro-actively contacted by one dedi-
cated member of the study staff.
New methods for contacting participants, which have
been used in other more recently started studies, including
use of internet, sms and e-mail, are currently being
explored [92, 252–262].
Data management and privacy protection
Data collected by measurements in the research centers are
directly entered onto written forms and into the electronic
database. Data collected by questionnaires are scanned and
manually entered into an electronic database by a com-
mercial bureau. Random samples of all questionnaires are
double checked by study staff members to monitor the
quality of this manual data entry process. The percentage
of mistakes is kept as low as possible and does not exceed
3% per questionnaire. Open text fields are entered into the
electronic database exactly as they are filled in on the
questionnaires. In a secondary stage, these open text fields
are cleaned and coded by a specialist in the relevant field.
All measurements are centrally checked by examination of
the data including their ranges, distributions, means, stan-
dard deviations, outliers and logical errors. Data outliers
and missing values are checked on the original forms and
might be imputed and subsequent appropriate statisticial
techniques are used [263–274]. The data of one specific
measurement are only distributed for analyses after data
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collection and preparation is completed for that measure-
ment for the whole cohort. Datasets needed for answering
specific research questions are centrally built from different
databases. All information in these datasets that enables
identification of a particular participant (including identi-
fication number used for the logistics of the study, names
and dates) is excluded before distribution to the research-
ers. The datasets for researchers include subject unique
identification numbers that enable feedback about one
subject to the data manager but do not enable identification
of that particular subject.
Statistical power
Due to expected missing values and loss to follow-up, most
analyses in the study are not based on data in all subjects.
Therefore, power calculations demonstrated in Tables 7
and 8 are based on 7,000 subjects in the whole cohort and
700 subjects in the focus cohort. Table 8 demonstrates that
for a normally distributed continuous outcome it is possible
to detect with a type I error of 5% and a type II error of
20% (power 80%) a difference of 0.11 SD in the whole
cohort and of 0.35 SD in the focus cohort if 10% of all
subjects has the relevant exposure. Table 8 presents for
dichotomous outcomes that with the same type I and II
errors, it is possible to detect a relative risk of 1.39 in the
whole cohort and of 2.48 in the focus cohort if 10% of all
subjects has the relevant exposure and the 1 year incidence
of the outcome of interest is 10%. Rates of most dichoto-
mous environmental and genetic exposures in the Gener-
ation R Study are expected to vary generally between 10
and 20%. The presented power calculations are rather
conservative since most studies will assess the effects of
continuously instead of dichotomous measured exposures
and studies may be focused on outcomes collected in more
than only 1 year. Furthermore, the Generation R Study has
a large number of measurements repeated over time, which
may increase the accuracy of measuring the true underlying
value and may thereby increase the statistical power for
these measurements.
Collaboration
The Generation R Study is conducted by several research
groups from the Erasmus Medical Center in close collabo-
ration with the Erasmus University Rotterdam and the
Municipal Health Service Rotterdam area. Since the data
collection is still ongoing and growing, the number of col-
laborating research groups in and outside the Netherlands is
expected to increase in the coming years. The study has an
open policy in regard to collaboration with other research
groups. Request for collaboration should primarily be
pointed to Vincent Jaddoe (v.jaddoe@erasmusmc.nl).
These requests are discussed in the Generation R Study
Management Team regarding their study aims, overlap with
ongoing studies, logistic consequences and financial con-
tributions. After approval of the project by the Generation R
Study Management Team and the Medical Ethical Com-
mittee of the Erasmus Medical Center, the collaborative
research project is embedded in one of the four research
areas supervised by the specific principal investigator.
Table 7 Effects sizes in standard deviation that can minimally be
detected according to the prevalence of the exposure
Proportion exposed
(%)
Whole cohort
(n = 7,000)
Focus cohort
(n = 700)
50 0.067 0.212
25 0.077 0.276
10 0.112 0.353
5 0.154 0.486
1 0.337 1.064
The presented effect sizes are detectable proportions of the standard
deviation with a type I error of 5% and a type II error of 20% (power
80%)
Table 8 Relative risks that can minimally be detected according to the prevalence of the exposure
Proportion exposed (%) Incidence (1 year) of outcome of interest
Whole cohort (n = 7,000) Focus cohort (n = 700)
10% 5% 1% 10% 5% 1%
50 1.23 1.33 1.83 1.83 2.28 4.94
25 1.26 1.38 1.94 1.96 2.46 5.41
10 1.39 1.56 2.42 2.48 3.26 7.92
5 1.55 1.80 3.09 3.20 4.39 11.74
1 2.36 3.04 6.83 7.75 11.61 37.55
The presented effect sizes are detectable relative risks with a type I error of 5% and a type II error of 20% (power 80%)
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